Sharing our perspective

Sharing perspectives leads to greater understanding and fuels innovation. The ​Optum Insights ​blog is where we share our perspective and challenge preconceptions to clear a new path forward.


  • Safety concerns regarding sterile compounded products from Cantrell Drug Company

    by
    • Optum Workers' Comp
    | Mar 14, 2018
    Tag Icon
    Compounded Medications, recall, FDA
    The U.S. Food and Drug Administration (FDA) issued a warning to health care professionals and is urging consumers to stop using sterile products, including opioid products and other medications intended for sterile injection, produced by Cantrell Drug Company in Little Rock, Arkansas. According to the FDA, they are “concerned about serious deficiencies in Cantrell’s compounding operations, including its processes to ensure quality and sterility assurance that put patient safety at risk.” If compounded injectable products are not sterile and are prepared in non-sterile environments, administering the medications to patients can result in serious, possibly life-threatening infections.


  • WCRC contractor transition webinar held with The Centers for Medicare and Medicaid Services

    by
    • Optum Workers' Comp
    | Mar 08, 2018
    Tag Icon
    Webinar, CMS, MSA
    The Centers for Medicare and Medicaid Services (CMS) held a webinar, March 7, 2018, to introduce Capitol Bridge LLC, our new WCRC contractor and review the transition plan.


  • FDA approves Apadaz™ - new short-acting opioid analgesic for acute pain

    by
    • Optum Workers' Comp
    | Mar 01, 2018
    Tag Icon
    Opioids, FDA
    KemPharm, Inc. announced that the U.S. Food and Drug Administration (FDA) approved its New Drug Application (NDA) for Apadaz (benzhydrocodone and acetaminophen), an immediate-release (short-acting) opioid analgesic combination product. Apadaz is intended for the short-term (no more than 14 days) management of acute pain that is severe enough to require an opioid analgesic and for which alternative treatments are inadequate.


  • Arizona Joins States Enacting Opioid Prescribing Restrictions

    by
    • Optum Workers' Comp
    | Feb 22, 2018
    Tag Icon
    Opioids
    Arizona’s Governor recently signed into law Senate Bill 1001 which, among other changes, establishes several new requirements for prescribing and dispensing opioids. Most notably, Arizona has gone the route of several other states over the last couple of years by enacting days’ supply and morphine milligram equivalent (MME) limits on prescriptions for these medications.